Ho AL, Foster NR, Zoroufy AJ, Campbell JD, et al. Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). J Clin Oncol 2022;40:4240-4249.
PMID: 35867947